These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7440331)

  • 1. Evaluation of a canine adenovirus type 2 strain as a replacement for infectious canine hepatitis vaccine.
    Bass EP; Gill MA; Beckenhauer WH
    J Am Vet Med Assoc; 1980 Aug; 177(3):234-42. PubMed ID: 7440331
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Attempts at evaluation of effectiveness of vaccination against Rubarth's disease in enzootic focus.
    Zwierzchowski J; Górski J
    Acta Microbiol Pol A; 1974; 6(1):140. PubMed ID: 4857226
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of dogs against canine hepatitis with Toronto A26-61 virus (kennel cough isolate) hexon antigen.
    Tribe GW; Wolff DC
    J Small Anim Pract; 1973 May; 14(5):251-5. PubMed ID: 4356888
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kennel cough and canine adenovirus vaccines in Australia.
    Studdert VP
    Aust Vet J; 1984 Jun; 61(6):198-9. PubMed ID: 6497798
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of canine adenovirus type 2 vaccine to control kennel cough syndrome.
    Powell KW
    Vet Med Small Anim Clin; 1979 Jun; 74(6):801-4. PubMed ID: 223268
    [No Abstract]   [Full Text] [Related]  

  • 7. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of protection after vaccination against infectious canine hepatitis virus (CAV/1).
    Fishman B; Scarnell J
    Vet Rec; 1976 Dec 18-25; 99(25-26):509. PubMed ID: 189480
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety evaluation of a canine hepatitis DNA vaccine.
    Liu FY; Guo RM; Zheng L; Lu YM; You H; Shuxia S; Wang JX; Sun SH
    Vaccine; 2008 Dec; 26(52):6925-8. PubMed ID: 18951942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High incidence of infectious canine hepatitis antibodies in the Turkish population and its relation to Au antigen].
    Okuyan M
    Mikrobiyol Bul; 1975; 9(2):101-12. PubMed ID: 180388
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectious canine hepatitis: detection of canine adenovirus type 1 by polymerase chain reaction.
    Kiss I; Matiz K; Bajmóci E; Rusvai M; Harrach B
    Acta Vet Hung; 1996; 44(2):253-8. PubMed ID: 8908749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-protective immunity to canine adenovirus type 2 by canine adenovirus type 1 vaccination.
    Emery JB; House JA; Brown WR
    Am J Vet Res; 1978 Nov; 39(11):1778-83. PubMed ID: 216291
    [No Abstract]   [Full Text] [Related]  

  • 14. Current canine vaccination programs: results of a questionnaire.
    Schultz RD
    Cornell Vet; 1978 Jan; 68 Suppl 7():62-9. PubMed ID: 204454
    [No Abstract]   [Full Text] [Related]  

  • 15. Intranasal vaccine trial for canine infectious tracheobronchitis (kennel cough).
    Glickman LT; Appel MJ
    Lab Anim Sci; 1981 Aug; 31(4):397-9. PubMed ID: 6273648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-sided immunologic relation between adenovirus and infectious canine hepatitis antigens.
    HELLER LA; SALENSTEDT CR
    Virology; 1960 Jul; 11():640-5. PubMed ID: 14400869
    [No Abstract]   [Full Text] [Related]  

  • 17. Serologic evidence that infectious canine hepatitis virus commonly infects humans and is related to human adenovirus type 8.
    Smith KO; Gehle WD; Kniker WT
    J Immunol; 1970 Oct; 105(4):1036-9. PubMed ID: 4319375
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of immunity to infectious canine hepatitis using a killed vaccine.
    Miller AS; Curtis R; Furminger IG
    Vet Rec; 1980 Apr; 106(15):343-4. PubMed ID: 7376387
    [No Abstract]   [Full Text] [Related]  

  • 19. Corneal oedema after vaccination of dogs with canine adenovirus vaccines.
    Watson AD; Farrow BR
    Aust Vet J; 1983 Dec; 60(12):384. PubMed ID: 6667222
    [No Abstract]   [Full Text] [Related]  

  • 20. Corneal oedema after vaccination of dogs with canine adenovirus 2.
    Blogg JR
    Aust Vet J; 1983 Sep; 60(9):284-5. PubMed ID: 6651694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.